DTIL
Price
$4.34
Change
+$0.21 (+5.08%)
Updated
Jul 3 closing price
Capitalization
48.12M
MDNAF
Price
$0.65
Change
+$0.01 (+1.56%)
Updated
Jul 3 closing price
Capitalization
51.58M
33 days until earnings call
Interact to see
Advertisement

DTIL vs MDNAF

Header iconDTIL vs MDNAF Comparison
Open Charts DTIL vs MDNAFBanner chart's image
Precision BioSciences
Price$4.34
Change+$0.21 (+5.08%)
Volume$61.35K
Capitalization48.12M
Medicenna Therapeutics
Price$0.65
Change+$0.01 (+1.56%)
Volume$1.04K
Capitalization51.58M
DTIL vs MDNAF Comparison Chart in %
Loading...
DTIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDNAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DTIL vs. MDNAF commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTIL is a Hold and MDNAF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (DTIL: $4.34 vs. MDNAF: $0.64)
Brand notoriety: DTIL and MDNAF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DTIL: 22% vs. MDNAF: 1%
Market capitalization -- DTIL: $48.12M vs. MDNAF: $52.38M
DTIL [@Biotechnology] is valued at $48.12M. MDNAF’s [@Biotechnology] market capitalization is $52.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DTIL’s FA Score shows that 1 FA rating(s) are green whileMDNAF’s FA Score has 0 green FA rating(s).

  • DTIL’s FA Score: 1 green, 4 red.
  • MDNAF’s FA Score: 0 green, 5 red.
According to our system of comparison, both DTIL and MDNAF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DTIL’s TA Score shows that 5 TA indicator(s) are bullish while MDNAF’s TA Score has 5 bullish TA indicator(s).

  • DTIL’s TA Score: 5 bullish, 5 bearish.
  • MDNAF’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both DTIL and MDNAF are a good buy in the short-term.

Price Growth

DTIL (@Biotechnology) experienced а +4.83% price change this week, while MDNAF (@Biotechnology) price change was -3.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

MDNAF is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDNAF($51.6M) has a higher market cap than DTIL($48.1M). DTIL YTD gains are higher at: 13.911 vs. MDNAF (-44.330). DTIL has higher annual earnings (EBITDA): -16.57M vs. MDNAF (-18.65M). DTIL has more cash in the bank: 77.2M vs. MDNAF (30M). MDNAF has less debt than DTIL: MDNAF (174K) vs DTIL (29.7M). DTIL has higher revenues than MDNAF: DTIL (51.1M) vs MDNAF (0).
DTILMDNAFDTIL / MDNAF
Capitalization48.1M51.6M93%
EBITDA-16.57M-18.65M89%
Gain YTD13.911-44.330-31%
P/E Ratio4.38N/A-
Revenue51.1M0-
Total Cash77.2M30M257%
Total Debt29.7M174K17,069%
FUNDAMENTALS RATINGS
DTIL vs MDNAF: Fundamental Ratings
DTIL
MDNAF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
40
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9799
PRICE GROWTH RATING
1..100
8586
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DTIL's Valuation (30) in the Biotechnology industry is in the same range as MDNAF (40) in the null industry. This means that DTIL’s stock grew similarly to MDNAF’s over the last 12 months.

DTIL's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MDNAF (100) in the null industry. This means that DTIL’s stock grew similarly to MDNAF’s over the last 12 months.

DTIL's SMR Rating (97) in the Biotechnology industry is in the same range as MDNAF (99) in the null industry. This means that DTIL’s stock grew similarly to MDNAF’s over the last 12 months.

DTIL's Price Growth Rating (85) in the Biotechnology industry is in the same range as MDNAF (86) in the null industry. This means that DTIL’s stock grew similarly to MDNAF’s over the last 12 months.

DTIL's P/E Growth Rating (100) in the Biotechnology industry is in the same range as MDNAF (100) in the null industry. This means that DTIL’s stock grew similarly to MDNAF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DTILMDNAF
RSI
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
MACD
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 11 days ago
89%
Bearish Trend 17 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
76%
Aroon
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
DTIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDNAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CGJTF80.267.05
+9.63%
Cargojet, Inc.
VHIBF8.070.03
+0.41%
VITALHUB CORP
KMERF35.55N/A
N/A
Komercni Banka A.S.
NGGTF14.23-0.47
-3.17%
National Grid PLC
SRSG0.07N/A
-5.32%
Spirits Time International, Inc.

DTIL and

Correlation & Price change

A.I.dvisor indicates that over the last year, DTIL has been loosely correlated with JBPHF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if DTIL jumps, then JBPHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DTIL
1D Price
Change %
DTIL100%
+1.88%
JBPHF - DTIL
47%
Loosely correlated
N/A
RENB - DTIL
36%
Loosely correlated
+3.44%
MURA - DTIL
33%
Loosely correlated
+2.79%
CLLS - DTIL
32%
Poorly correlated
-4.24%
LEGN - DTIL
30%
Poorly correlated
-0.75%
More

MDNAF and

Correlation & Price change

A.I.dvisor tells us that MDNAF and DTIL have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MDNAF and DTIL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDNAF
1D Price
Change %
MDNAF100%
-0.71%
DTIL - MDNAF
27%
Poorly correlated
+1.88%
HRTX - MDNAF
26%
Poorly correlated
+2.33%
ARWR - MDNAF
25%
Poorly correlated
-0.65%
CRBU - MDNAF
23%
Poorly correlated
N/A
MRVI - MDNAF
22%
Poorly correlated
+0.75%
More